opment set + a random sample out of the
remaining 60 patients?).
I am looking forward to your comments.
Best regards, Andreas.
____
Andreas Lindauer
University of Bonn
Department of Clinical Pharmacy
An der Immenburg 4
D-53121 Bonn
phone:+49 2
?
I would like to know how the more experienced NMusers handle this.
Thanks in advance, Andreas.
Andreas Lindauer
University of Bonn
Department of Clinical Pharmacy
An der Immenburg 4
D-53121 Bonn
phone:+49 228 73 5781
fax: +49 228 73 9757
.
Andreas Lindauer
University of Bonn
Department of Clinical Pharmacy
An der Immenburg 4
D-53121 Bonn
phone:+49 228 73 5781
fax: +49 228 73 9757
.
Regards, Andreas.
________
Andreas Lindauer
Department of Clinical Pharmacy
Institute of Pharmacy
University of Bonn
An der Immenburg 4
D-53121 Bonn
phone: + 49 228 73 5781
fax: + 49 228 73 9757
Nick,
In your code example for the estimation of a 'relative bioavailability'
wouldn't it be necessary to use a logit transformation to keep F1 between 0
and 1? Something like: F1 = 1/(1+exp(BSV_F1))
Regards, Andreas.
________
Andreas Lindauer
Jacob,
I would say you missed the scale parameter for the peripheral compartment.
So adding S3=V3 should fix your problem.
Regards, Andreas.
Andreas Lindauer
Department of Clinical Pharmacy
Institute of Pharmacy
University of Bonn
An der Immenburg 4
D-53121
(t=0) )
3. Simulated time of maximal response (eg. Tmax)
Thanks and best regards, Andreas.
Andreas Lindauer
Department of Clinical Pharmacy
Institute of Pharmacy
University of Bonn
An der Immenburg 4
D-53121 Bonn
phone: + 49 228 73 5781
fax
eck
(visual, numerical, statistical) that will be compared to distribution
statistics of the observations then you should include residual error.
Nick
andreas lindauer wrote:
>
> Dear NMUSERS,
>
>
>
> The recent discussion about simulation with a nonparametric method
limit using NONMEM VI,” Journal of Pharmacokinetics and
Pharmacodynamics 35, no. 4 (August 2008): 401-421.
Just that the right people get their merits...
Best regards, Andreas.
Dr. Andreas Lindauer
Modeling & Simulation and in vivo ADME
Dept. of Pharmacokinetics and Metabolism
R&
Senior PK position
We are a leading pharmaceutical company with several research centers
throughout Europe. Our company focuses on the discovery and development
of innovative medicines in the area of cardiovascular, central nervous
system, infectious diseases, dermatology and inflammation. We have
Dear Philp,
You may also want to have a look at the open-source R package campsis
(https://calvagone.github.io/).
Below is some R-code that illustrates how you can easily simulate individual
profiles taking the ETAs from a NONMEM output table.
Best regards, Andreas.
--
11 matches
Mail list logo